These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27544755)

  • 41. Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts.
    Chung H; Jung YM; Shin DH; Lee JY; Oh MY; Kim HJ; Jang KS; Jeon SJ; Son KH; Kong G
    Int J Cancer; 2008 Feb; 122(4):816-22. PubMed ID: 17957784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Wogonin, a plant derived small molecule, exerts potent anti-inflammatory and chondroprotective effects through the activation of ROS/ERK/Nrf2 signaling pathways in human Osteoarthritis chondrocytes.
    Khan NM; Haseeb A; Ansari MY; Devarapalli P; Haynie S; Haqqi TM
    Free Radic Biol Med; 2017 May; 106():288-301. PubMed ID: 28237856
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.
    Chian S; Thapa R; Chi Z; Wang XJ; Tang X
    Biochem Biophys Res Commun; 2014 May; 447(4):602-8. PubMed ID: 24747074
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.
    Lee TK; Poon RT; Wo JY; Ma S; Guan XY; Myers JN; Altevogt P; Yuen AP
    Cancer Res; 2007 Sep; 67(18):8800-9. PubMed ID: 17875721
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation.
    Xu X; Zhang X; Zhang Y; Yang L; Liu Y; Huang S; Lu L; Kong L; Li Z; Guo Q; Zhao L
    Sci Rep; 2017 Feb; 7():39950. PubMed ID: 28150717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma.
    Osman AA; Arslan E; Bartels M; Michikawa C; Lindemann A; Tomczak K; Yu W; Sandulache V; Ma W; Shen L; Wang J; Singh AK; Frederick MJ; Spencer ND; Kovacs J; Heffernan T; Symmans WF; Rai K; Myers JN
    Clin Cancer Res; 2023 Apr; 29(7):1344-1359. PubMed ID: 36689560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Hsp90 inhibitor 17-(allylamino)-17-demethoxygeldanamycin increases cisplatin antitumor activity by inducing p53-mediated apoptosis in head and neck cancer.
    Roh JL; Kim EH; Park HB; Park JY
    Cell Death Dis; 2013 Dec; 4(12):e956. PubMed ID: 24336076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activation.
    Noman ASM; Parag RR; Rashid MI; Islam S; Rahman MZ; Chowdhury AA; Sultana A; Jerin C; Siddiqua A; Rahman L; Nayeem J; Akther S; Baidya S; Shil RK; Rahman M; Shirin A; Mahmud R; Hossain SMI; Sumi SA; Chowdhury A; Basher SB; Hasan A; Bithy S; Aklima J; Chowdhury N; Hasan MN; Banu T; Chowdhury S; Hossain MM; Yeger H; Farhat WA; Islam SS
    Cell Death Dis; 2020 Aug; 11(8):663. PubMed ID: 32814771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
    Shen W; Liang B; Yin J; Li X; Cheng J
    Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses.
    Lee S; Lim MJ; Kim MH; Yu CH; Yun YS; Ahn J; Song JY
    Free Radic Biol Med; 2012 Aug; 53(4):807-16. PubMed ID: 22684019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer.
    Hayden A; Douglas J; Sommerlad M; Andrews L; Gould K; Hussain S; Thomas GJ; Packham G; Crabb SJ
    Urol Oncol; 2014 Aug; 32(6):806-14. PubMed ID: 24837013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancement of cisplatin-induced colon cancer cells apoptosis by shikonin, a natural inducer of ROS in vitro and in vivo.
    He G; He G; Zhou R; Pi Z; Zhu T; Jiang L; Xie Y
    Biochem Biophys Res Commun; 2016 Jan; 469(4):1075-82. PubMed ID: 26740178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
    Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
    Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combining TRAIL and liquiritin exerts synergistic effects against human gastric cancer cells and xenograft in nude mice through potentiating apoptosis and ROS generation.
    Xie R; Gao CC; Yang XZ; Wu SN; Wang HG; Zhang JL; Yan W; Ma TH
    Biomed Pharmacother; 2017 Sep; 93():948-960. PubMed ID: 28715876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5.
    Qin X; Guo H; Wang X; Zhu X; Yan M; Wang X; Xu Q; Shi J; Lu E; Chen W; Zhang J
    Genome Biol; 2019 Jan; 20(1):12. PubMed ID: 30642385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Wogonin protects against cisplatin-induced acute kidney injury by targeting RIPK1-mediated necroptosis.
    Meng XM; Li HD; Wu WF; Ming-Kuen Tang P; Ren GL; Gao L; Li XF; Yang Y; Xu T; Ma TT; Li Z; Huang C; Zhang L; Lv XW; Li J
    Lab Invest; 2018 Jan; 98(1):79-94. PubMed ID: 29200200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wogonin triggers apoptosis in human osteosarcoma U-2 OS cells through the endoplasmic reticulum stress, mitochondrial dysfunction and caspase-3-dependent signaling pathways.
    Lin CC; Kuo CL; Lee MH; Lai KC; Lin JP; Yang JS; Yu CS; Lu CC; Chiang JH; Chueh FS; Chung JG
    Int J Oncol; 2011 Jul; 39(1):217-24. PubMed ID: 21573491
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer.
    Homma S; Ishii Y; Morishima Y; Yamadori T; Matsuno Y; Haraguchi N; Kikuchi N; Satoh H; Sakamoto T; Hizawa N; Itoh K; Yamamoto M
    Clin Cancer Res; 2009 May; 15(10):3423-32. PubMed ID: 19417020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isoliquiritigenin pretreatment attenuates cisplatin induced proximal tubular cells (LLC-PK1) death and enhances the toxicity induced by this drug in bladder cancer T24 cell line.
    Patricia Moreno-Londoño A; Bello-Alvarez C; Pedraza-Chaverri J
    Food Chem Toxicol; 2017 Nov; 109(Pt 1):143-154. PubMed ID: 28870684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of SESN1 reduces cisplatin and hyperthermia resistance through increasing reactive oxygen species (ROS) in human maxillary cancer cells.
    Narita N; Ito Y; Takabayashi T; Okamoto M; Imoto Y; Ogi K; Tokunaga T; Matsumoto H; Fujieda S
    Int J Hyperthermia; 2018 Dec; 35(1):269-278. PubMed ID: 30300027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.